Device Trial Radar · NCT04129580
reSET-O RCT (Randomized Controlled Trial)
Last checked: Nov 19, 2026Latest source record: Nov 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Sep 15, 2020
Primary completion
Jul 14, 2023
Study completion Sep 19, 2024
Sponsor
- Lead sponsor
- Milton S. Hershey Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Columbia University; Pear Therapeutics, Inc.; National Institutes of Health (NIH); Research Foundation for Mental Hygiene, Inc.
- First posted
- Oct 17, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized controlled trial research study will be evaluating an app, reSET-O, owned by Pear Therapeutics, Inc., to evaluate treatment retention rates in individuals with opioid use disorder after initiating medication assisted treatment.
Conditions
- Opioid-use Disorder
Interventions
reSET-O appDevice
The reSET-O app, owned by Pear Therapeutics, Inc., is designed to work as cognitive behavioral therapy, adjunctive to medication assisted treatment, for opioid use disorder. The app provides psychoeducation related to opioid use and dependence, coping skills, and skills to avoid relapse,
Primary outcomes
What the sponsor says the trial is designed to measure.
- Retention in Treatment on MAT for 6 Months After Enrolling in the StudyTime frame: 6 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pennsylvania Psychiatric Institute
Harrisburg, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.